[go: up one dir, main page]

AR020032A1 - Derivados de 1,3 -metil eritromicina. - Google Patents

Derivados de 1,3 -metil eritromicina.

Info

Publication number
AR020032A1
AR020032A1 ARP000102485A ARP000102485A AR020032A1 AR 020032 A1 AR020032 A1 AR 020032A1 AR P000102485 A ARP000102485 A AR P000102485A AR P000102485 A ARP000102485 A AR P000102485A AR 020032 A1 AR020032 A1 AR 020032A1
Authority
AR
Argentina
Prior art keywords
compounds
derivatives
formula
methyl erythromycin
erythromycin
Prior art date
Application number
ARP000102485A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR020032A1 publication Critical patent/AR020032A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Se refiere a compuestos de formula 1 y a sales, promedicamentos y solvatos de éstos farmacéuticamente aceptables, en los que R1, R2, R3, R4, R5, Rf, A, Xe Y son como se definieron en la descripcion. La invencion también se refiere a composiciones faramcéuticas que contienen los compuestos de formulas 1, aprocedimienTos de utilizacion de los compuestos de formula 1 en el tratamiento de infecciones y a procedimientos de preparacion de los compuestos de formula 1.
ARP000102485A 1999-05-24 2000-05-22 Derivados de 1,3 -metil eritromicina. AR020032A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13546899P 1999-05-24 1999-05-24

Publications (1)

Publication Number Publication Date
AR020032A1 true AR020032A1 (es) 2002-03-27

Family

ID=22468240

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000102485A AR020032A1 (es) 1999-05-24 2000-05-22 Derivados de 1,3 -metil eritromicina.

Country Status (32)

Country Link
US (2) US20030100518A1 (es)
EP (1) EP1180110A1 (es)
JP (1) JP2003500414A (es)
KR (1) KR20020016799A (es)
CN (1) CN1351608A (es)
AP (1) AP2001002302A0 (es)
AR (1) AR020032A1 (es)
AU (1) AU3832100A (es)
BG (1) BG106127A (es)
BR (1) BR0010938A (es)
CA (1) CA2373117C (es)
CZ (1) CZ20013733A3 (es)
DZ (1) DZ3045A1 (es)
EA (1) EA200100983A1 (es)
EE (1) EE200100613A (es)
HK (1) HK1045523A1 (es)
HR (1) HRP20010866A2 (es)
HU (1) HUP0201516A3 (es)
IL (1) IL145739A0 (es)
IS (1) IS6128A (es)
MA (1) MA26740A1 (es)
NO (1) NO20015172L (es)
OA (1) OA11945A (es)
PA (1) PA8495101A1 (es)
PE (1) PE20010171A1 (es)
PL (1) PL352720A1 (es)
SK (1) SK15162001A3 (es)
TN (1) TNSN00108A1 (es)
TR (1) TR200103395T2 (es)
UY (1) UY26161A1 (es)
WO (1) WO2000071557A1 (es)
ZA (1) ZA200109595B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1060A (en) 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
AP9801420A0 (en) 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
CZ20011512A3 (cs) * 1998-11-03 2001-09-12 Pfizer Products Inc. Nová makrolidová antibiotika
KR20020002380A (ko) 1999-01-27 2002-01-09 실버스타인 아써 에이. 케톨라이드 항생물질
US6514944B2 (en) 1999-04-16 2003-02-04 Kosan Biosciences, Inc. Macrolide antiinfective agents
CN1373767A (zh) 1999-04-16 2002-10-09 奥索-麦克尼尔药品公司 酮式大环内酯抗菌剂
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
ATE340183T1 (de) 1999-04-16 2006-10-15 Kosan Biosciences Inc Antiinfektiöse makrolidderivate
US6939861B2 (en) 1999-04-16 2005-09-06 Kosan Biosciences, Inc. Amido macrolides
US6451768B1 (en) 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
HK1045523A1 (zh) 1999-05-24 2002-11-29 辉瑞产品公司 13-甲基红霉素衍生物
ES2222966T3 (es) 2000-06-30 2005-02-16 Pfizer Products Inc. Macrolidos antibioticos.
GB0127349D0 (en) 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
NZ533282A (en) 2001-12-05 2006-09-29 Ortho Mcneil Pharm Inc 6-O-Acyl ketolide derivatives of erythromycine useful as antibacterials
WO2003090761A1 (en) * 2002-04-25 2003-11-06 Abbott Laboratories 9-oxime macrolide antibacterials
EP1579864A1 (en) * 2002-04-25 2005-09-28 Abbott Laboratories Oxolide antibacterials
GB0225384D0 (en) 2002-10-31 2002-12-11 Glaxo Group Ltd Novel compounds
WO2005067564A2 (en) * 2004-01-07 2005-07-28 Enanta Pharmaceuticals, Inc. 6-11 bicyclic erythromycin derivatives
DK1836211T3 (da) 2004-12-21 2010-05-17 Pfizer Prod Inc Makrolider
DE602007006663D1 (de) 2006-06-12 2010-07-01 Univ Ramot Verfahren zur behandlung von krebs
CN101175322B (zh) * 2007-11-16 2010-12-15 华为技术有限公司 一种小区选择的方法
KR101043637B1 (ko) * 2009-07-13 2011-06-24 태석정공 주식회사 휴대용 듀얼 모니터의 카메라 모듈 결합구조
AR085286A1 (es) * 2011-02-21 2013-09-18 Taisho Pharmaceutical Co Ltd Derivado de macrolido sustituido en la posicion c-4
US10987370B2 (en) 2012-12-24 2021-04-27 Ramot At Tel-Aviv University Ltd. Methods of inducing read-through of a nonsense mutation associated with ataxia telangiectasia, Rett syndrome or spinal muscular atrophy by erythromycin or azithromycin
MX377459B (es) 2013-04-04 2025-03-10 Harvard College Macrolidos y metodos para su preparacion y uso.
WO2016057798A1 (en) 2014-10-08 2016-04-14 President And Fellows Of Harvard College 14-membered ketolides and methods of their preparation and use
WO2016154591A1 (en) 2015-03-25 2016-09-29 President And Fellows Of Harvard College Macrolides with modified desosamine sugars and uses thereof

Family Cites Families (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US52328A (en) * 1866-01-30 Improved mode of attaching car-wheels to axles
US61856A (en) * 1867-02-05 Enos s
US61857A (en) * 1867-02-05 Improvement in top-drivers or spinners
US13665A (en) * 1855-10-09 Daguerreotype-plate holder
US77302A (en) * 1868-04-28 mat son
US111317A (en) * 1871-01-31 Improvement in culinary vessels
US100742A (en) * 1870-03-15 Improvement in lawn-mowers
US100518A (en) * 1870-03-08 Roland s
US61858A (en) * 1867-02-05 Improved washing machine
US50254A (en) * 1865-10-03 Improvement in portable scales
US13281A (en) * 1855-07-17 Churn
US25937A (en) * 1859-11-01 ballou
US156027A (en) * 1874-10-20 Improvement in loom-shuttles
US40007A (en) * 1863-09-22 Improvement in railroad-car brakes
US13662A (en) * 1855-10-09 Improvement in sewing-machines
US3923784A (en) * 1973-09-10 1975-12-02 Hoffmann La Roche Erythromycin a derivatives
YU43116B (en) * 1979-04-02 1989-04-30 Pliva Pharm & Chem Works Process for preparing 11-aza-4-o-cladinosyl-6-o-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one(11-aza-10-deox
US4331803A (en) * 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
YU43006B (en) * 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
JPS61103890A (ja) * 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシンａ誘導体
JPS61229895A (ja) * 1985-04-03 1986-10-14 Nippon Zeon Co Ltd 保護化デス−ｎ−メチルエリスロマイシン誘導体
GB8521402D0 (en) * 1985-08-28 1985-10-02 Beecham Group Plc Chemical compounds
US4672056A (en) * 1985-11-12 1987-06-09 Abbott Laboratories Erythromycin A derivatives and method of use
EP0283055B1 (en) * 1987-09-03 1990-08-29 SOUR PLIVA farmaceutska, Kemijska prehrambena i kozmeticka industrija, n.sol.o. 10-dihydro-10-deoxo-11-azaerythronolide-a-compounds, methods and intermediates for the manufacture thereof and their use in pharmaceuticals and in the manufacture thereof
US5141926A (en) * 1990-04-18 1992-08-25 Abbott Laboratories Erythromycin derivatives
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of erythromycin derivatives
US5824513A (en) * 1991-01-17 1998-10-20 Abbott Laboratories Recombinant DNA method for producing erythromycin analogs
US6060234A (en) 1991-01-17 2000-05-09 Abbott Laboratories Polyketide derivatives and recombinant methods for making same
CA2064634C (en) 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
US5985844A (en) * 1992-03-26 1999-11-16 Merck & Co., Inc. Homoerythromycin A derivatives modified at the 4"-and 8A-positions
US5523399A (en) 1991-12-27 1996-06-04 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide derivatives
FR2691464B1 (fr) 1992-05-21 1995-06-02 Roussel Uclaf Nouveaux dérivés de la 1-oxa 6-azacyclopentadécane 13,15-dione, leur procédé de préparation et leur application comme médicaments.
US5414926A (en) * 1992-10-09 1995-05-16 Sumitomo Wiring Systems, Ltd. Terminal crimping apparatus
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
US5332807A (en) 1993-04-14 1994-07-26 Merck & Co., Inc. Process of producing 8A- and 9A-azalide antibiotics
FR2702480B1 (fr) * 1993-03-09 1995-04-28 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
HRP931480B1 (en) * 1993-12-08 1997-08-31 Sour Pliva 9a-N-(N'-CARBAMONYL) and 9a-N-(N'-THIOCARBAMONYL) DERIVATES OF 9-DEOXO-9a-HOMOERYTHROMYCIN A
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2727969B1 (fr) 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2732023B1 (fr) 1995-03-22 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2732684B1 (fr) 1995-04-06 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6274715B1 (en) * 1995-11-08 2001-08-14 Abbott Laboratories Tricyclic erythromycin derivatives
US5747466A (en) * 1995-11-08 1998-05-05 Abbott Laboratories 3-deoxy-3-descladinose derivatives of erythromycins A and B
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2745290B1 (fr) * 1996-02-28 1998-04-03 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6077943A (en) * 1996-03-01 2000-06-20 Takeda Chemical Industries, Ltd. Method of producing erythromycin derivative
US5719272A (en) 1996-04-02 1998-02-17 Abbott Laboratories 2'-protected 3'-dimethylamine, 9-etheroxime erythromycin A derivatives
JP2000509712A (ja) * 1996-05-07 2000-08-02 アボツト・ラボラトリーズ ６―ｏ―置換エリスロマイシン及びその製造方法
BR9708929A (pt) * 1996-05-07 1999-08-03 Abbott Lab Composto composição farmacêutica e processos para controlar uma infecção bacteriana em um mamífero e para preparar compostos de macrólidos
US5750510A (en) * 1997-04-04 1998-05-12 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
FR2748746B1 (fr) * 1996-05-14 1998-08-14 Hoechst Marion Roussel Inc Nouveau procede d'isomerisation du radical methyle en 10 de derives de l'erythromycine
DE19626036A1 (de) 1996-06-28 1998-01-02 Whitaker Corp Optischer Steckverbinder
CN1179046C (zh) 1996-07-05 2004-12-08 拜奥蒂卡技术有限公司 新型红霉素、其制备方法、用途和含其的药物组合物
US6271255B1 (en) * 1996-07-05 2001-08-07 Biotica Technology Limited Erythromycins and process for their preparation
FR2751656B1 (fr) 1996-07-24 1998-10-16 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
US5804565A (en) 1996-09-24 1998-09-08 Taisho Pharmaceutical Co., Ltd. Erythromycin A derivatives
FR2754821B1 (fr) 1996-10-23 2003-04-04 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
WO1998023628A1 (fr) * 1996-11-27 1998-06-04 Taisho Pharmaceutical Co., Ltd. Derives de l'erythromicine a
FR2757168B1 (fr) 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2760017B1 (fr) 1997-02-27 1999-04-30 Hoechst Marion Roussel Inc Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments
WO1998040392A1 (fr) * 1997-03-10 1998-09-17 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
AU6932098A (en) 1997-05-09 1998-12-08 Pfizer Products Inc. Erythromycin derivatives
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
US20020025937A1 (en) 2000-03-20 2002-02-28 Yong-Jin Wu 9-oxime erythromycin derivatives
ID24529A (id) 1997-06-11 2000-07-20 Pfizer Prod Inc Turunan-turunan 9-oksima eritromisin
US6407074B1 (en) * 1997-06-11 2002-06-18 Pfizer Inc C-4″-substituted macrolide derivatives
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
US5868549A (en) * 1997-08-29 1999-02-09 Hk Systems, Inc. Palletizer with air assisted slide plate assembly and indexing pallet hoist
PA8461401A1 (es) * 1997-10-29 2000-05-24 Pfizer Prod Inc Derivados de eritromicina triciclicos
HN1998000159A (es) * 1997-10-29 1999-02-09 Monsanto Co Derivados de 9- amino - 3 ceto eritromicina
WO1999029709A1 (fr) 1997-12-11 1999-06-17 Hokuriku Seiyaku Co., Ltd. Derives d'erythromycine
AP9801420A0 (en) 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
EP0941998B1 (en) * 1998-03-03 2004-09-01 Pfizer Products Inc. 3,6-ketal macrolide antibiotics
FR2777282B1 (fr) 1998-04-08 2001-04-20 Hoechst Marion Roussel Inc Nouveaux derives de la 2-fluoro 3-de((2,6-dideoxy 3-c-methyl 3-0-methyl-alpha-l-ribohexopyranosyl) oxyl) 6-o-methyl 3-oxo erythromycine, leur procede de preparation et leur application a la synthese de principes actifs de medicaments
US6248719B1 (en) 1998-06-03 2001-06-19 Pfizer Inc Tricyclic 3-keto derivatives of 6-O-methylerthromycin
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
ES2243066T3 (es) * 1998-09-22 2005-11-16 Pfizer Products Inc. Antibioticos de carbamato y carbazato cetolida.
US6100240A (en) * 1998-10-09 2000-08-08 Pfizer Inc Macrolide derivatives
FR2785612A1 (fr) 1998-11-10 2000-05-12 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
CZ20011512A3 (cs) 1998-11-03 2001-09-12 Pfizer Products Inc. Nová makrolidová antibiotika
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків
FR2786188B1 (fr) 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
KR20020002380A (ko) 1999-01-27 2002-01-09 실버스타인 아써 에이. 케톨라이드 항생물질
FR2789392B1 (fr) 1999-02-04 2001-10-05 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
CN1373767A (zh) 1999-04-16 2002-10-09 奥索-麦克尼尔药品公司 酮式大环内酯抗菌剂
US20020061857A1 (en) 1999-04-23 2002-05-23 Yong-Jin Wu 9-amino-3-oxo erythromycin derivatives
US20020077302A1 (en) 1999-04-23 2002-06-20 Yong-Jin Wu Tricyclic erythromycin derivatives
US6355620B1 (en) * 1999-05-14 2002-03-12 Abbott Laboratories C-2 modified erythromycin derivatives
HK1045523A1 (zh) 1999-05-24 2002-11-29 辉瑞产品公司 13-甲基红霉素衍生物
EP1114826A3 (en) 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
EP1122261A3 (en) 2000-01-31 2001-09-26 Pfizer Products Inc. 13 and 14-membered antibacterial macrolides
EP1146051A3 (en) 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A derivatives
US20020061856A1 (en) 2000-04-24 2002-05-23 Yong-Jin Wu Novel tricyclic erythromycin derivatives
ES2222966T3 (es) 2000-06-30 2005-02-16 Pfizer Products Inc. Macrolidos antibioticos.
US20020115621A1 (en) 2000-08-07 2002-08-22 Wei-Gu Su Macrolide antibiotics
US20020111317A1 (en) 2000-09-25 2002-08-15 Leonard Katz Sixteen-membered macrolide compounds

Also Published As

Publication number Publication date
IL145739A0 (en) 2002-07-25
HK1045523A1 (zh) 2002-11-29
HRP20010866A2 (en) 2003-06-30
AU3832100A (en) 2000-12-12
NO20015172L (no) 2002-01-23
UY26161A1 (es) 2000-12-29
CA2373117A1 (en) 2000-11-30
ZA200109595B (en) 2003-05-28
EE200100613A (et) 2003-02-17
IS6128A (is) 2001-10-26
MA26740A1 (fr) 2004-12-20
BG106127A (bg) 2002-05-31
PL352720A1 (en) 2003-09-08
JP2003500414A (ja) 2003-01-07
NO20015172D0 (no) 2001-10-23
HUP0201516A2 (en) 2002-08-28
DZ3045A1 (fr) 2004-03-27
CA2373117C (en) 2006-02-28
TR200103395T2 (tr) 2002-04-22
CN1351608A (zh) 2002-05-29
US6777543B2 (en) 2004-08-17
TNSN00108A1 (fr) 2002-05-30
US20030100518A1 (en) 2003-05-29
AP2001002302A0 (en) 2001-10-25
PE20010171A1 (es) 2001-02-10
OA11945A (en) 2006-04-13
KR20020016799A (ko) 2002-03-06
HUP0201516A3 (en) 2003-03-28
US20030229031A1 (en) 2003-12-11
BR0010938A (pt) 2002-03-19
EP1180110A1 (en) 2002-02-20
PA8495101A1 (es) 2002-08-26
WO2000071557A1 (en) 2000-11-30
CZ20013733A3 (cs) 2002-11-13
SK15162001A3 (sk) 2003-02-04
EA200100983A1 (ru) 2002-10-31

Similar Documents

Publication Publication Date Title
AR020032A1 (es) Derivados de 1,3 -metil eritromicina.
PA8494101A1 (es) Derivados heterociclicos utiles como agentes anticancerosos
CO4810375A1 (es) Derivados de 9-amino-3-ceto eritromicina
PA8547701A1 (es) Nucleosidos 4 substituidos.
GT200100137A (es) Pro-drogas de derivados de 4-fenil-piridina.
MXPA02012905A (es) Derivados de colquinol como agentes de dano vascular..
PA8490601A1 (es) Derivados quinolin-2-ona sustituidos con heteroarilo utiles como agentes anticancerigenos.
ATE450533T1 (de) Carboxamidderivate
PA8591701A1 (es) Derivados de pirrolopirimidina
ATE316083T1 (de) Adamantanderivate
PA8472301A1 (es) Derivados de isotiazol utiles como agentes anticancerosos
NO20085077L (no) Nye forbindelser
AR023574A1 (es) Compuestos de azepinindol tetraciclico,composiciones farmaceuticas y el uso de dichos compuestos para preparar un medicamento, e intermediarios
AR023423A1 (es) Derivados de adamantano, procedimientos para su preparacion, composicion farmaceutica, procedimiento para la preparacion de la composicion farmaceutica, yuso de dichos derivados para la manufactura de medicamentos
SE9904505D0 (sv) Novel compounds
SV2005001979A (es) "pirido[2,3-d]pirimidina-2,4-diaminas como inhibidores de pde 2 " ref. pc25123a
PA8451801A1 (es) Derivados de la 9-oxima eritromicina
ES2243579T3 (es) Derivados de pirazolopirideno.
ATE372995T1 (de) Benzo(b)(1,4)dioxepinderivate
ATE386725T1 (de) Heterocyclylverbindungen
PA8568101A1 (es) Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos, y procedimientos para su uso
CL2003002565A1 (es) Compuestos derivados de 3h-quinazolin-4-ona, su proceso de preparacion, composicion farmaceutica que los contiene, y uso en el tratamiento y prevencion de enfermedades mediadas por inhibidores de mao-b, tales como la enfermedad de alzheimer y demenci
PT992509E (pt) Novos derivados macrolidos
UY27980A1 (es) Indoles 2,7-sustituidos
AR007108A1 (es) Agentes antitumorales y antivirales alquilantes, procedimiento para su preparacion, utilizacion de los mismos para la fabricacion de un medicamento y composicion farmaceutica que contiene a dichos agentes.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal